Clinical Trial Update: Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) [Phase 2]

View source ↗

Summary

This clinical trial update reports the efficacy of dupilumab in patients with chronic rhinosinusitis without nasal polyps in a Phase 2 study. The trial has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Without Nasal Polyps

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Chronic Sinusitis | Phase 2 | Status: COMPLETED